References
- Arab A, Karimipoor M, Rajabi A, et al. Molecular characterization of β-thalassemia intermedia: A report from Iran. Mol Biol Rep. 2011;38(7):4321–4326.
- Giardine B, Borg J, Viennas E, et al. Updates of the HbVar database of human hemoglobin variants and thalassemia mutations. Nucleic Acids Res. 2014;42(Database issue):D1063–D1069. (http://globin.cse.psu.edu).
- Hajihoseini S, Motovali-Bashi M, Honardoost MA, Alerasool N. Tetra-primer ARMS PCR optimization for detection of IVS-II-I (G-A) and FSC 8/9 InsG mutations in β-thalassemia major patients in Isfahan population. Iran J Public Health. 2015;44(3):380–387.
- Cao A, Galanello R. β-Thalassemia. Genet Med. 2010;12(2):61–76.
- Taher A, Isma’eel H, Cappellini MD. Thalassemia intermedia: Revisited. Blood Cells Mol Dis. 2006;37(1):12–20.
- Sagar CS, Kumar R, Sharma DC, Kishor P. Alpha hemoglobin stabilizing protein: Its causal relationship with the severity of beta thalassemia. Blood Cells Mol Dis. 2015;55(2):104–107.
- Liu S, Jiang H, Wu MY, et al. Thalassemia intermedia caused by 16p13.3 sectional duplication in a β-thalassemia heterozygous child. Pediatr Hematol Oncol. 2015;32(5):349–353.
- Farashi S, Bayat N, Faramarzi Garous N, et al. Interaction of an α-globin gene triplication with β-globin gene mutations in Iranian patients with β-thalassemia intermedia. Hemoglobin. 2015;39(3):201–206.
- Mohammdai-Asl J, Ramezani A, Norozi F, et al. The influence of polymorphisms in disease severity in β-thalassemia. Biochem Genet. 2015;53(9–10):235–243.
- Rund D, Rachmilewitz E. β-Thalassemia. N Engl J Med. 2005;353(11):1135–1146.
- Neishabury M, Azarkeivan A, Oberkanins C, et al. Molecular mechanisms underlying thalassemia intermedia in Iran. Genet Test. 2008;12(4):549–556.
- Karimi M, Yarmohammadi H, Farjadian S, et al. β-Thalassemia intermedia from southern Iran: IVS-II-1 (G→A) is the prevalent thalassemia intermedia allele. Hemoglobin. 2002;26(2):147–154.
- Najmabadi H, Karimi-Nejad R, Sahebjam S, et al. The β-thalassemia mutation spectrum in the Iranian population. Hemoglobin. 2001;25(3):285–296.
- Akbari MT, Izadi P, Izadyar M, et al. Molecular basis of thalassemia intermedia in Iran. Hemoglobin. 2008;32(5):462–470.
- Miri Moghaddam E, Zadeh Vakili A, Rouhani Z, et al. Molecular basis and prenatal diagnosis of β thalassemia among Balouch population in Iran. Prenat Diag. 2011;31(8):788–791.
- Old J. Screening and genetic diagnosis of haemoglobin disorders. Blood Rev. 2003;17(1):43–53.
- Ahmad NN, Cu-Unjieng AB, Donoso LA. Modification of standard proteinase K/phenol method for DNA isolation to improve yield and purity from frozen blood. J Med Genet. 1995;32(2):129–130.
- Old J, Varawalla N, Weatherall D. Rapid detection and prenatal diagnosis of β-thalassaemia: Studies in Indian and Cypriot populations in the UK. Lancet. 1990;336(8719):834–837.
- Miri-Moghaddam E, Zadeh-Vakili A, Nikravesh A, et al. Sistani population: A different spectrum of β-thalassemia mutations from other ethnic groups of Iran. Hemoglobin. 2013;37(2):138–147.
- Bowden D, Vickers M, Higgs D. A PCR-based strategy to detect the common severe determinants of α thalassaemia. Br J Haematol. 1992;81(1):104–108.
- Yavarian M, Harteveld CL, Batelaan D, et al. Molecular spectrum of β-thalassemia in the Iranian Province of Hormozgan. Hemoglobin. 2001;25(1):35–43.
- Verma IC, Kleanthous M, Saxena R, et al. Multicenter study of the molecular basis of thalassemia intermedia in different ethnic populations. Hemoglobin. 2007;31(4):439–452.
- Nagar R, Sinha S, Raman R. Genotype-phenotype correlation and report of novel mutations in β-globin gene in thalassemia patients. Blood Cells Mol Dis. 2015;55(1):10–14.
- Shamoon RP, Al-Allawi NA, Cappellini MD, et al. Molecular basis of β-thalassemia intermedia in Erbil Province of Iraqi Kurdistan. Hemoglobin. 2015;39(3):178–183.
- Adekile AD, Azab AF, Al-Sharida SI, et al. Clinical and molecular characteristics of non-transfusion-dependent thalassemia in Kuwait. Hemoglobin. 2015;39(5):320–326.
- Thein SL. The molecular basis of β-thalassemia. Cold Spring Harb Perspect Med. 2013;3(5):a011700.
- Harteveld C, Yavarian M, Zorai A, et al. Molecular spectrum of α-thalassemia in the Iranian population of Hormozgan: three novel point mutation defects. Am J Hematol. 2003;74(2):99–103.